Back to Search Start Over

The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas

Authors :
Hugues Duffau
Karine Michaud
Francois-Xavier Ferracci
CCSD, Accord Elsevier
UNIROUEN - UFR Santé (UNIROUEN UFR Santé)
Université de Rouen Normandie (UNIROUEN)
Normandie Université (NU)-Normandie Université (NU)
CHU de Québec–Université Laval
Université Laval [Québec] (ULaval)
Institut des Neurosciences de Montpellier (INM)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Neurochirurgie [Hôpital Gui de Chauliac]
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Gui de Chauliac [Montpellier]
Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM)
Source :
Critical Reviews in Oncology/Hematology, Critical Reviews in Oncology/Hematology, Elsevier, 2019, 138, pp.148--155. ⟨10.1016/j.critrevonc.2019.04.009⟩
Publication Year :
2019
Publisher :
HAL CCSD, 2019.

Abstract

International audience; Early and maximal safe surgical resection optionally followed by adjuvant treatment is currently recommended in diffuse low-grade glioma (DLGG). Although this management delays malignant transformation (MT), recurrence will most often occur. Because this relapse usually arises locally, reoperation can be considered, with possible further chemotherapy/radiotherapy. However, due to a prolonged overall survival, a large spectrum of unusual recurrence patterns begins to emerge during long-term follow-up, beyond the classical slow and local tumor re-growth. We review various atypical patterns of DLGG relapse, we discuss their pathophysiological mechanisms and how to adapt the treatment(s). Those patterns include very diffuse, ipsi- or bilateral gliomatosis-like progression, multicentric recurrence with emergence of remote low-grade or high-grade glioma, leptomeningeal dissemination, acute (early or delayed) local MT or bulky relapse into the operating cavity. This landscape of recurrence patterns may allow physicians to elaborate new tailored therapeutic strategies and scientists to develop original hypotheses for basic research.

Details

Language :
English
ISSN :
10408428
Database :
OpenAIRE
Journal :
Critical Reviews in Oncology/Hematology, Critical Reviews in Oncology/Hematology, Elsevier, 2019, 138, pp.148--155. ⟨10.1016/j.critrevonc.2019.04.009⟩
Accession number :
edsair.doi.dedup.....8447a075d0e3033cc9acda72465b0948